Schedule of Related Party Payables (Details) - Chemomab Therapeutics Ltd [Member] - USD ($) $ in Thousands |
Jun. 30, 2026 |
Dec. 31, 2025 |
Dec. 31, 2024 |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Defined Benefit Plan Disclosure [Line Items] | |||||||||
| Employees and related expenses | $ 803 | $ 656 | [1] | $ 934 | [1] | ||||
| Accrued expenses | $ 493 | 337 | [2] | 1,536 | [2] | ||||
| Related Party [Member] | |||||||||
| Defined Benefit Plan Disclosure [Line Items] | |||||||||
| Employees and related expenses | 458 | 531 | |||||||
| Accrued expenses | 74 | 75 | |||||||
| Total | $ 532 | $ 606 | |||||||
| |||||||||
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|